Results 151 to 160 of about 1,892,351 (211)

Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease-directed progress. [PDF]

Br J Haematol
Ngo TQ, Georgiou M, McLornan DP, Harrison CN.   +3 more
europepmc   +1 more source

Cardiogenic shock managed with phlebotomy: an unusual case of end-stage cardiac hemochromatosis. [PDF]

Eur Heart J Case Rep
Majeed Z, Finet JE, Hanna M, Kwon D, Agdamag AC.   +4 more
europepmc   +1 more source

Risk of thromboembolic events in patients with polycythaemia vera: a study based on german health claims data. [PDF]

Ann Hematol
Manz KC, Morouj B, Feuerbach M, Ehneß R, Lenti P, Barnstorf I, Höer A, Al-Ali HK.   +7 more
europepmc   +1 more source

Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026. [PDF]

Curr Hematol Malig Rep
Abu-Zeinah G, Hobbs GS, Rampal RK, Lee SE, Gill H, Komrokji R, Tashi T, Bose P, Mascarenhas J, Yacoub A, Oh ST, Shimoda K, Reeves BN, Duan M, Yu LH, Qin A, Prchal JT, Kaushansky K, Mesa RA.   +18 more
europepmc   +1 more source

Ropeginterferon alfa-2b in Polycythemia Vera: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Bakht D, Haris HM, Sania Z, Bahadri MMS, Dad A, Mirza AR, Nayyar S, Amyn M, Zahid K, Awais MN, Faheem M, Waheed M, Alvi AO.   +12 more
europepmc   +1 more source

A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib. [PDF]

Blood Adv
Palandri F, Dedola A, Caocci G, Rossi E, Elli EM, Sartor C, Latagliata R, Pugliese N, Morsia E, Binotto G, Mendicino F, Tieghi A, Benevolo G, Martino B, D'Addio A, Tiribelli M, Cilloni D, Crugnola M, Cavalca F, Scalzulli E, Lanza F, Pane F, Palumbo GA, Heidel FH, De Stefano V, Breccia M, Branzanti F.   +26 more
europepmc   +1 more source

Hyperferritinemia: Pathophysiology, Etiologies, and Diagnostic Approach. [PDF]

Eur J Haematol
Kim Y, Landry TC, Seifer L, LaVasseur C, Martens K, Shatzel J.   +5 more
europepmc   +1 more source

Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study. [PDF]

Blood Adv
Pemmaraju N, Markova A, Masarova L, Reaven N, Funk S, Ferguson TW, Bellamy L, Dinh P, Oyuela P, Valone F, Molina A, Gupta S.   +11 more
europepmc   +1 more source

P535: Therapeutic phlebotomy in the management of iron overload in pyruvate kinase deficiency

Genetics in Medicine Open
Valerie Sency, Bea Torres-Fults, Heng Wang   +2 more
openaire   +1 more source

Reply: Iron deposition in steatotic liver disease-A matter of compartment, but can it be a target for treatment? [PDF]

Hepatol Commun
Sohal A, Kowdley KV.
europepmc   +1 more source